Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Urovant Sciences Ltd

(NASDAQ: UROV)
Add to Portfolio
+0.48 (+6.36%)
as of Jun 14, 2019

Last 8.03
Change +0.48 (+6.36%)
Open 7.90
Prev. Close 7.55
Today's Range
7.56
8.11
52wk Range
4.05
14.49
Volume 53,900
Avg Volume 86,910
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
UROV +6.36% -16.70% -31.07%
DJIA -0.07% -0.49% +3.63%
S&P 500 -0.16% +0.47% +3.76%

Key Statistics

Annual EPS N/A
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 243,800
Weighted Alpha -38.70
Standard Deviation +1.13
Profit Margin N/A
Beta N/A

Growth Rates

YTD +21.85%

Opinion

Sell Hold Buy

Recent Headlines

Urovant Sciences Appoints James Robinson to its Board

BusinessWire via COMTEX - Wed Mar 06, 08:00AM EST
Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced James Robinson, President and(full story)
UROV: 8.03 (+0.48), ALKS: 21.89 (-0.52)